HDAC6 and Miyoshi myopathy: As an approach to overriding IMiD resistance in MM, one study proposed combining pomalidomide and the HDAC6-selective inhibitor, A452, which similarly caused increased CRBN expression and decreased MYC and IKZF1/3 expression [69].